Browse Contents
Special Offers
Articles submitted between January 01st to December 31st, 2018 will be published as Open Access. Open Access publishing provides greater accessibility to the article. To view some of the Open access articles in the journal, please click here
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
| Forthcoming Special Issues |
| Please visit again after some time to view these Issues. |
| Special Issues - In-Press |
Oxidative stress in Neurodegenerative and Psychiatric disordersGuest Editor(s): Puneet Kumar, Ashish Baldi Download Description |
| Published Special Issues |
Zebrafish PsychopharmacologyGuest Editor(s): Robert T. Gerlai Download Description |
Current Psychopharmacology
,Volume 7
-Number 1
Biography Free Content
Meet Our Editorial Board Member
Preface Free Content
Preface
Editorial Free Content
Adverse Effects of Psychopharmacologic Products in Pediatrics: Primum Non Nocere!
, 7(1): 4 - 5Donald E. Greydanus
DOI: 10.2174/221155600701180716121401
Adverse Effects of Psychopharmacologic Products in Pediatrics: Primum Non Nocere!
Review Article Free Content
Immunologic Effects of Psychotropic Pharmaco-Therapeutics
, 7(1): 6 - 10Andrey Leonov*, Donald E. Greydanus and H.C. Athens
DOI: 10.2174/2211556006666171019155320
Immunologic Effects of Psychotropic Pharmaco-Therapeutics
Review Article Free Content
Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists
, 7(1): 11 - 14Myrtha Gregoire-Bottex* and Katherine Soe
DOI: 10.2174/2211556007666180328150248
Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists
Review Article Free Content
Management of Side-Effects of Selective-Serotonin Re-Uptake Inhibitors in Children and Adolescents
, 7(1): 15 - 22Dilip R. Patel *, Katie J. Udenberg, Patricia Choi and Neelkamal Soares
DOI: 10.2174/2211556007666180402143023
Management of Side-Effects of Selective-Serotonin Re-Uptake Inhibitors in Children and Adolescents
Review Article Free Content
Management of Adverse Effects from Atypical Antipsychotics
, 7(1): 23 - 35Ahsan Nazeer* and Joseph L. Calles
DOI: 10.2174/2211556007666180220162945
Management of Adverse Effects from Atypical Antipsychotics
Review Article Free Content
Management of Adverse Effects of Sleep Medications in Pediatrics
, 7(1): 36 - 48Neelkamal Soares* and Shibani Kanungo
DOI: 10.2174/2211556007666180131153440
Management of Adverse Effects of Sleep Medications in Pediatrics
Current Psychopharmacology, Volume 7 (2018) - Number 2
This issue is in progress but contains articles that are final and fully citable.
Articles Ahead of Print
Protein Chimera-based Ca2+ Rewiring as a Treatment Modality for Neurodegeneration
Netra Unni Rajesh and Anam Qudrat*
View Abstract
Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
M. Akmal Yazdani, Md. Jamir Anwar, Bushra Parveen and Divya Vohora*
View Abstract
A Pilot Study of Plasma Antipsychotic Drugs Concentrations of First Episode Patients with Psychosis From Epirus - Greece
Vassiliki A. Boumba*, Petros Petrikis, Lisbeth Patteet, Maria Baou , Georgios Rallis, Apostolos Metsios, Andreas Karambas, Kristof Maudens and Venetsanos Mavreas
View Abstract
Neurobehavioral Effects of β-Escin
Hayder M. Alkuraishy*, Ali I. Al-Gareeb, Ali K. Albuhadilly, Iman N. Al-Bajaji, Huda Jaber Alkuraishy and Marta Chagas Monterio
View Abstract
Substance Use Disorder Related to Kratom (Mitragyna speciosa) Use in Malaysia
Mohammad F. I. Leong Abdullah, Darshan Singh, Balasingam K. Vicknasingam and Christian P. Muller
View Abstract
Systemic Injections of Primidone Cause Wake-Inducing Effects in Rats
Mireille Salas-Crisostomo, Maria Franco-Tormo, Niurka Trujillo-Paredes, Gloria Arankowsky-Sandoval, Oscar Arias-Carrion, Sergio Machado, Eric Murillo-Rodriguez and Eric Murillo-Rodríguez
View Abstract
Psychopharmacology for Patients with Parkinson’s Disease and Deep Brain Stimulation: Lessons Learned in an Academic Center
Andreea Seritan*, Peter Ureste, Tammy Duong and Jill L. Ostrem M.D
View Abstract
Abstracts Ahead of Print
Oral monosodium glutamate administration differentially affects novelty-induced behaviours, behavioural despair and place preference in male and female mice
Onaolapo AY, Olawore OI, Yusuf FO, Adeyemo AM, Adewole IO and Onaolapo OJ*
View Abstract
Editor's Choice
Mechanistic Description of Natural Herbs in the Treatment of Dementia: A Systematic Review
, 2018; 7(2): 149 - 164Bapi Gorain*, Hira Choudhury, Manisha Pandey, Hasbi Laili Bt Mohd Zaki, Nuurul Izzati Bt Bakar, Nur Hanis Bt Hamdhan, Nor Aniza Bt Musa, Nurul Fadhilah Bt Mustafa, Jaya Sree Sangkari, Nur Ain Athirah Bt Azmi, Lui Park Yeang and Prashant Kesharwani
DOI: 10.2174/2211556007666180420124544
Management of Adverse Effects from Atypical Antipsychotics
, 2018; 7(1): 23 - 35Ahsan Nazeer* and Joseph L. Calles
DOI: 10.2174/2211556007666180220162945
Meta-analysis of Native Studies as Regards the Effectiveness of Antidepressants on Deficit Syndrome of Schizophrenia: A Systematic Review
, 2017; 6(2): 148 - 157Saeed S. Shafti*
DOI: 10.2174/2211556006666170419161746
Psychiatric Polypharmacy, Etiology and Potential Consequences
, 2017; 6(1): 12 - 26Sonali Sarkar*
DOI: 10.2174/2211556005666160916124719
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96 - 138Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
A Comparison Between Quetiapine and Aripiprazole for Treatment of Schizophrenia: A Double Blind Contrast
, 2016; 5(1): 13 - 19Saeed S. Shafti and Hamid Kaviani
DOI: 10.2174/2211556005666160301231207
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
, 2015; 4(2): 96 - 102Claudia Becerra-Palars, Javier Amado-Lerma, Alejandra Andrade, Rafael Campuzano and Emilio Montemayor
DOI: 10.2174/2211556005666151216225423
Decreased Incidence of Readmissions in First Episode Psychosis in Treatment with Long - Acting Injectable Antipsychotics
, 2015; 4(1): 52 - 57Alba T. Privat, Daniel B. Baquero, Anna M. Santacana and Victor P. Sola
DOI: 10.2174/2211556004666150918194108
Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder
, 2014; 3(3): 219 - 225Saeed Shoja Shafti
DOI: 10.2174/221155600303150629162749
Safety Profile of the Use of Second Generation Antipsychotics in the Child and Adolescent Population
, 2014; 3(2): 146 - 150Michael Shapiro, Mariam Rahmani, Adrienne Eisner and Mathew Nguyen
DOI: 10.2174/221155600302150302112302
Open Access Articles
The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
, 2018; 7: 1 - 22 (E-Pub Ahead of Print)Murray Johns*
Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
, 2018; 7: 1 - 9 (E-Pub Ahead of Print)M. Akmal Yazdani, Md. Jamir Anwar, Bushra Parveen and Divya Vohora*
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96 - 138Caio Maximino, Bruna P. Costa and Monica G. Lima
Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
, 2015; 4(2): 96 - 102Claudia Becerra-Palars, Javier Amado-Lerma, Alejandra Andrade, Rafael Campuzano and Emilio Montemayor
Most Cited Articles
Pharmacological Manipulation of Shoaling Behavior in Zebrafish
, 2016; 5(2): 180-193.Soaleha Shams and Robert T. Gerlai
DOI: 10.2174/2211556005666160607094906
Odyssey of ‘Negative Symptoms’ of Schizophrenia: Rehabilitation vs Stigmatization
, 2015; 4(1): 40-51.Saeed Shoja Shafti
DOI: 10.2174/2211556004666150918193742
The Novel Tank Test: Handling Stress and the Context Specific Psychopharmacology of Anxiety
, 2016; 5(2): 169-179.Steven Tran and Robert T. Gerlai
DOI: 10.2174/2211556005666160519144414
Relevance of Test- and Subject-Related Factors on Inhibitory Avoidance (Performance) of Zebrafish for Psychopharmacology Studies
, 2016; 5(2): 152-168.Remy Manuel, Marnix Gorissen and Ruud van den Bos
DOI: 10.2174/2211556005666160526111427
A Review of Monoaminergic Neuropsychopharmacology in Zebrafish, 6 Years Later: Towards Paradoxes and their Solution
, 2016; 5(2): 96-138.Caio Maximino, Bruna P. Costa and Monica G. Lima
DOI: 10.2174/2211556005666160527105104
Zebrafish as an Animal Model to Study Epileptic Seizures and Epileptic Syndromes
, 2016; 5(2): 194-210.Ben H.M. Mussulini, Suelen Baggio, Luana Moro, Renato D. Dias, Maria E. Calcagnotto, Eduardo P. Rico and Diogo L. de Oliveira
DOI: 10.2174/2211556005666160615090734
Zebrafish Models to Study Fear and Anxiety
, 2016; 5(2): 139-151.Adam D. Collier and David J. Echevarria
DOI: 10.2174/2211556005666160608124610
Most Accessed Articles
Management of Adverse Effects from Medications Used to Treat Substance Use Disorders
, 2018; 7(1): 49-57.Joseph L. Calles*
DOI: 10.2174/2211556006666171124161420
Management of Adverse Effects of Sleep Medications in Pediatrics
, 2018; 7(1): 36-48.Neelkamal Soares* and Shibani Kanungo
DOI: 10.2174/2211556007666180131153440
Management of Adverse Effects from Atypical Antipsychotics
, 2018; 7(1): 23-35.Ahsan Nazeer* and Joseph L. Calles
DOI: 10.2174/2211556007666180220162945
Dermatologic Effects of Psychopharmacologic Agents in the Pediatric Population
, 2018; 7(1): 58-68.Ai Yamasaki, Andrey Leonov* and Donald Greydanus
DOI: 10.2174/2211556007666180126112844
Adverse Effects of Non-Stimulant ADHD Drugs: Atomoxetine, Alpha-Agonists
, 2018; 7(1): 11-14.Myrtha Gregoire-Bottex* and Katherine Soe
DOI: 10.2174/2211556007666180328150248
Management of Side-Effects of Selective-Serotonin Re-Uptake Inhibitors in Children and Adolescents
, 2018; 7(1): 15-22.Dilip R. Patel*, Katie J. Udenberg, Patricia Choi and Neelkamal Soares
DOI: 10.2174/2211556007666180402143023
Colon Targeted Press Coated Tablets of Venlafaxine Hydrochloride for Treatment of Depression
, 2018; 7(1): 69-82.Pravin Kumar*, Babli Devi, Bhumika Thakur and Mahendra Singh Ashawat
DOI: 10.2174/2211556007666180126112405
Immunologic Effects of Psychotropic Pharmaco-Therapeutics
, 2018; 7(1): 6-10.Andrey Leonov*, Donald E. Greydanus and H.C. Athens
DOI: 10.2174/2211556006666171019155320
6-hydroxydopamine Lesion of the Mesolimbic Dopamine System Alters Morphine-Induced Conditioned Reinforcement
, 2018; 7(1): 83-90.S. Tiffany Donaldson* and Brooke Plotkin
DOI: 10.2174/2211556007666180131154111
Webmaster Contact: info@benthamscience.net